Key facts
Extracted from this filing and checked against the source text.
Auditor Changes
SEC 8-K Item 4.01/4.02
confidence 0.9
CareMax, Inc. dismissed PricewaterhouseCoopers LLP as its auditor.
- Action
- dismissal
- Auditor
- PricewaterhouseCoopers LLP
Exact text from the filing
Effective February 3, 2025, the Audit Committee (the “ Audit Committee ”) of the Board of Directors of the Company authorized the dismissal of PricewaterhouseCoopers LLP (“ PwC ”) as the Company’s independent registered public accounting firm.
View on SEC.gov
Distress & Bankruptcy
SEC 8-K Item 1.03
confidence 0.9
CareMax, Inc. entered chapter 11 in United States Bankruptcy Court for the Northern District of Texas (petition 2024-11-17).
- Proceeding
- chapter 11
- Court
- United States Bankruptcy Court for the Northern District of Texas
- Petition
- 2024-11-17
Exact text from the filing
On November 17, 2024, (the “Petition Date”) CareMax, Inc. and its affiliated debtors in the above-captioned chapter 11 cases (each a “Debtor” and, collectively, the “Debtors” or the “Company”) commenced voluntary cases (the “Chapter 11 Cases”) under chapter 11 of title 11
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jose R. Rodriguez departed as Director at CareMax, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kevin Wirges departed as Chief Financial Officer at CareMax, Inc..
- Action
- ceased
- Role
- Chief Financial Officer
Exact text from the filing
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Paul Rundell departed as Chief Restructuring Officer at CareMax, Inc..
- Action
- ceased
- Role
- Chief Restructuring Officer
Exact text from the filing
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bryan Cho departed as Director at CareMax, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert N. Michaelson was appointed as Plan Administrator at CareMax, Inc..
- Action
- appointed
- Role
- Plan Administrator
Exact text from the filing
On the Effective Date, Robert N. Michaelson of Advisory Trust Group, LLC, the Plan Administrator, was appointed as the sole officer and director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Edward J. Borkowski departed as Director at CareMax, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Vincent Omachonu departed as Director at CareMax, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Carlos de Solo departed as Chief Executive Officer at CareMax, Inc..
- Action
- ceased
- Role
- Chief Executive Officer
Exact text from the filing
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kevin Berg departed as Director at CareMax, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ralph De La Torre, M.D. departed as Director at CareMax, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Alberto de Solo departed as Chief Operating Officer at CareMax, Inc..
- Action
- ceased
- Role
- Chief Operating Officer
Exact text from the filing
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ryan O’Quinn departed as Director at CareMax, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.94
CareMax, Inc. completed a disposition involving RHG Network, LLC for (i) $10 million, as set forth in the ACO SPA, and (ii) certain 2023 and 2024 Medicare Shared Savings Program payments, as set forth in the ACO SPA (closed 2025-02-03).
- Action
- disposition
- Counterparty
- RHG Network, LLC
- Consideration
- (i) $10 million, as set forth in the ACO SPA, and (ii) certain 2023 and 2024 Medicare Shared Savings Program payments, as set forth in the ACO SPA
- Closing
- 2025-02-03
Exact text from the filing
As previously disclosed, on November 17, 2024, the Company, Sparta Merger Sub I LLC, a Delaware limited liability company and a subsidiary of the Company (" Merger Sub I "), and Sparta Merger Sub II LLC, a Delaware limited liability company and a subsidiary of the Company (together with Merger Sub I, the " Sellers "), entered into a securities purchase agreement (the " ACO SPA ") with RHG Network, LLC (the " ACO Buyer ") pursuant to which the ACO Buyer agreed to purchase, subject to the terms and conditions contained therein, 100% of the outstanding equity securities of CareMax Accountable Care Network, LLC and CareMax National Care Network, LLC, each a subsidiary of the Company (together, the " Acquired Companies "), representing the Medicare Shared Savings Program portion of the Company's management services organization. The acquisition of the Acquired Companies by the ACO Buyer pursuant to the ACO SPA closed on February 3, 2025.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.94
CareMax, Inc. completed a disposition involving ClareMedica Viking, LLC for (i) a cash payment of $35 million and (ii) units of ClareMedica Health Partners, LLC, a wholly-owned subsidiary of Buyer Parent, having an aggregate value of $6 (closed 2025-02-03).
- Action
- disposition
- Counterparty
- ClareMedica Viking, LLC
- Consideration
- (i) a cash payment of $35 million and (ii) units of ClareMedica Health Partners, LLC, a wholly-owned subsidiary of Buyer Parent, having an aggregate value of $6
- Closing
- 2025-02-03
Exact text from the filing
date, under the terms of the Stalking Horse APA, the Buyer acquired the Acquired Assets and assumed the Acquired Liabilities from the Seller Group for (i) a cash payment of $35 million and (ii) units of ClareMedica Health Partners, LLC, a wholly-owned subsidiary of Buyer Parent, having an aggregate value of $65 million. --- EX-99.1 (EX-99.1) --- EX-99.1
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.